Literature DB >> 30211064

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer.

Chin-Chen Pan1.   

Abstract

Entities:  

Year:  2018        PMID: 30211064      PMCID: PMC6127537          DOI: 10.21037/tau.2018.07.11

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
  20 in total

1.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

2.  Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.

Authors:  Kim E M van Kessel; Kirstin A van der Keur; Lars Dyrskjøt; Ferran Algaba; Naeromy Y C Welvaart; Willemien Beukers; Ulrika Segersten; Bastian Keck; Tobias Maurer; Tatjana Simic; Marcus Horstmann; Marc-Oliver Grimm; Gregers G Hermann; Karin Mogensen; Arndt Hartmann; Niels Harving; Astrid C Petersen; Jørgen B Jensen; Kerstin Junker; Joost L Boormans; Francisco X Real; Núria Malats; Per-Uno Malmström; Torben F Ørntoft; Ellen C Zwarthoff
Journal:  Clin Cancer Res       Date:  2018-01-24       Impact factor: 12.531

Review 3.  Biomarkers in bladder cancer.

Authors:  Ian Proctor; Kai Stoeber; Gareth H Williams
Journal:  Histopathology       Date:  2010-06-23       Impact factor: 5.087

4.  A molecular signature in superficial bladder carcinoma predicts clinical outcome.

Authors:  Lars Dyrskjøt; Karsten Zieger; Mogens Kruhøffer; Thomas Thykjaer; Jens L Jensen; Hanne Primdahl; Natasha Aziz; Niels Marcussen; Klaus Møller; Torben F Orntoft
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

5.  Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.

Authors:  Lars Dyrskjøt; Thomas Reinert; Ferran Algaba; Emil Christensen; Daan Nieboer; Gregers G Hermann; Karin Mogensen; Willemien Beukers; Mirari Marquez; Ulrika Segersten; Søren Høyer; Benedicte P Ulhøi; Arndt Hartmann; Robert Stöhr; Sven Wach; Roman Nawroth; Kristina Schwamborn; Cane Tulic; Tatjana Simic; Kerstin Junker; Niels Harving; Astrid C Petersen; Jørgen B Jensen; Bastian Keck; Marc-Oliver Grimm; Marcus Horstmann; Tobias Maurer; Ewout W Steyerberg; Ellen C Zwarthoff; Francisco X Real; Núria Malats; Per-Uno Malmström; Torben F Ørntoft
Journal:  Eur Urol       Date:  2017-06-02       Impact factor: 20.096

Review 6.  Bladder cancer: translating molecular genetic insights into clinical practice.

Authors:  Liang Cheng; Shaobo Zhang; Gregory T MacLennan; Sean R Williamson; Antonio Lopez-Beltran; Rodolfo Montironi
Journal:  Hum Pathol       Date:  2010-11-24       Impact factor: 3.466

7.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

Review 8.  Quality of life aspects of bladder cancer: a review of the literature.

Authors:  M F Botteman; C L Pashos; R S Hauser; B L Laskin; A Redaelli
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

9.  FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.

Authors:  Silvia Hernández; Elena López-Knowles; Josep Lloreta; Manolis Kogevinas; Roberto Jaramillo; Alex Amorós; Adonina Tardón; Reina García-Closas; Consol Serra; Alfredo Carrato; Núria Malats; Francisco X Real
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

10.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

View more
  2 in total

1.  Computational Analysis Identifies Novel Biomarkers for High-Risk Bladder Cancer Patients.

Authors:  Radosław Piliszek; Anna A Brożyna; Witold R Rudnicki
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 2.  The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma.

Authors:  Ho Won Kang; Wun-Jae Kim; Seok Joong Yun
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.